| Metric | Q1'26 | Q2'26 | Change |
|---|---|---|---|
| Organic Revenue Growth | 10% (Q1 2026) | 6% (Q2 2026) | -400 bps deceleration |
| Unit Case Volume Growth | 3% (Q1 2026) | 5% (Q2 2026) | +200 bps acceleration |
| Price/Mix | 2% (Q1 2026) | 2% (Q2 2026) | Flat but composition shifted |
| Comparable EPS | $0.86 (+18% YoY) | $0.97 (+11% YoY) | Growth rate decelerating |
| North America Volume | 4% (Q1 2026) | 3% (Q2 2026) | -100 bps deceleration |
| Asia Pacific Price/Mix | -6% (Q1 2026) | Negative (unspecified) | Still deeply negative |
| Comparable Gross Margin | -30 bps (Q1 2026) | +120 bps (Q2 2026) | +150 bps swing |
| Comparable Operating Margin | +70 bps (Q1 2026) | +90 bps (Q2 2026) | +20 bps improvement |
| Free Cash Flow | $1.8B (Q1 2026) | $6.9B YTD | Strong generation |
| Net Debt/EBITDA | 1.6x (Q1 2026) | 1.4x (Q2 2026) | -0.2x improvement |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.